Skip to main content

Intravenous Ketamine for Acute Pain - US vs. UK Experience

Presentation Icon
This webinar - held on 22 March 2023 - was produced through a collaboration of the International Association for the Study of Pain's Acute Pain Special Interest Group (APSIG) and the Pain Nurse Network (PNN). APSIG's goal is to advance and promote the understanding of mechanisms, assessment, prevention, and management of acute pain, while PNN is dedicated to improving patient experience through joint working and educational events/projects.
                                                                                            
Intravenous ketamine infusions have been used for decades to treat acute pain, but widespread variability in patient selection, treatment parameters, and monitoring indicates a need for the synthesis of consensus guidelines. This webinar - produced through a collaboration of the International Association for the Study of Pain and the Pain Nurse Network - explored the use intravenous ketamine in both the United States and the United Kingdom to help identify similarities and differences in their approaches to its utilization. Attention was paid to the pharmacology of ketamine, how patients are identified for its use, a review of its safety and patient monitoring, and how it can be implemented for acute pain outside of the critical care setting.

                                                                                           


Participants included:
--
Oluwatobi Hunter, DNP, PMGT-BC, AGACNP-BC, Veterans Affairs Palo Alto Health Care System, California, USA
--
Gillian Chumbley, PhD, RN, Imperial College Healthcare NHS Trust, London, UK
-- Rianne L.M. van Boekel, PhD, RN, Radboud University Medical Center, Netherlands (moderator)
-- Felicia Cox, FRCN, Royal Brompton & Harefield Hospitals, London, UK (moderator)

You can access this item by buying entire course

Buy entire course: